Immunomedics (IMMU) – Reuters
-
Buffett-backed Snowflake's value doubles in stock market's largest software debut
-
Tech, healthcare mega deals boost virus-stricken M&A market
-
Gilead's shares rise after $21 billion deal for Immunomedics
-
AstraZeneca bets up to $6 billion on new Daiichi cancer drug
-
Drug developers take fresh aim at 'guided-missile' cancer drugs
Back to IMMU Stock Lookup